首页> 外国专利> TREATMENT OF UTERINE FIBROIDS BY INTRAVAGINAL ADMINISTRATION OF A LOW DOSE OF SELECTIVE PROGESTERONE RECEPTOR MODULATOR (SPRM), ANTI-PROGESTIN, OR ANTI-PROGESTATIONAL AGENT

TREATMENT OF UTERINE FIBROIDS BY INTRAVAGINAL ADMINISTRATION OF A LOW DOSE OF SELECTIVE PROGESTERONE RECEPTOR MODULATOR (SPRM), ANTI-PROGESTIN, OR ANTI-PROGESTATIONAL AGENT

机译:低剂量选择性孕酮受体调节剂(SPRM),抗前列腺素或抗前列腺剂的经阴道内给药治疗子宫肌瘤

摘要

A method and intravaginal drug delivery device for reducing size of a uterine fibroid in a female in need thereof are provided. The method includes administering intravaginally to the female a therapeutically effective amount of an active agent, wherein the agent is delivered on a delivery device directly to uterine fibroid, wherein said amount is able to significantly reduce the size of the uterine fibroid, wherein the active agent is any one of selective progesterone receptor modulator (SPRM), an anti-progestin agent, and an anti-progestational agent.
机译:提供了一种用于减少有此需要的女性子宫肌瘤大小的方法和阴道内药物输送装置。该方法包括对女性阴道内施用治疗有效量的活性剂,其中该剂在递送装置上直接递送至子宫肌瘤,其中所述量能够显着减小子宫肌瘤的大小,其中该活性剂是选择性孕激素受体调节剂(SPRM),抗孕激素药和抗孕药中的任何一种。

著录项

  • 公开/公告号US2019201418A1

    专利类型

  • 公开/公告日2019-07-04

    原文格式PDF

  • 申请/专利权人 ARSTAT INC.;

    申请/专利号US201916295577

  • 发明设计人 ARKADY RUBIN;

    申请日2019-03-07

  • 分类号A61K31/575;A61K31/567;A61K9;

  • 国家 US

  • 入库时间 2022-08-21 12:07:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号